Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Targeting the antigen processing and presentation pathway to overcome resistance to immune checkpoint therapy.
Front Immunol. 2022 Jul 22;13:948297. doi: 10.3389/fimmu.2022.948297. eCollection 2022.
Front Immunol. 2022.
PMID: 35936007
Free PMC article.
Review.
ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function.
D'Amico S, D'Alicandro V, Compagnone M, Tempora P, Guida G, Romania P, Lucarini V, Melaiu O, Falco M, Algeri M, Pende D, Cifaldi L, Fruci D.
D'Amico S, et al. Among authors: tempora p.
Front Immunol. 2021 Nov 30;12:778103. doi: 10.3389/fimmu.2021.778103. eCollection 2021.
Front Immunol. 2021.
PMID: 34917091
Free PMC article.
Item in Clipboard
Impact of Natural Occurring ERAP1 Single Nucleotide Polymorphisms within miRNA-Binding Sites on HCMV Infection.
Melaiu O, D'Amico S, Tempora P, Lucarini V, Fruci D.
Melaiu O, et al. Among authors: tempora p.
Int J Mol Sci. 2020 Aug 15;21(16):5861. doi: 10.3390/ijms21165861.
Int J Mol Sci. 2020.
PMID: 32824160
Free PMC article.
Review.
Item in Clipboard
Dendritic Cells: Behind the Scenes of T-Cell Infiltration into the Tumor Microenvironment.
Lucarini V, Melaiu O, Tempora P, D'Amico S, Locatelli F, Fruci D.
Lucarini V, et al. Among authors: tempora p.
Cancers (Basel). 2021 Jan 23;13(3):433. doi: 10.3390/cancers13030433.
Cancers (Basel). 2021.
PMID: 33498755
Free PMC article.
Review.
Item in Clipboard
ERAP1 and ERAP2 Enzymes: A Protective Shield for RAS against COVID-19?
D'Amico S, Tempora P, Lucarini V, Melaiu O, Gaspari S, Algeri M, Fruci D.
D'Amico S, et al. Among authors: tempora p.
Int J Mol Sci. 2021 Feb 8;22(4):1705. doi: 10.3390/ijms22041705.
Int J Mol Sci. 2021.
PMID: 33567739
Free PMC article.
Review.
Item in Clipboard
Two bullets in the gun: combining immunotherapy with chemotherapy to defeat neuroblastoma by targeting adrenergic-mesenchymal plasticity.
D'Amico S, Tempora P, Gragera P, Król K, Melaiu O, De Ioris MA, Locatelli F, Fruci D.
D'Amico S, et al. Among authors: tempora p.
Front Immunol. 2023 Oct 2;14:1268645. doi: 10.3389/fimmu.2023.1268645. eCollection 2023.
Front Immunol. 2023.
PMID: 37849756
Free PMC article.
Review.
Item in Clipboard
Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma.
Lucarini V, Melaiu O, D'Amico S, Pastorino F, Tempora P, Scarsella M, Pezzullo M, De Ninno A, D'Oria V, Cilli M, Emionite L, Infante P, Di Marcotullio L, De Ioris MA, Barillari G, Alaggio R, Businaro L, Ponzoni M, Locatelli F, Fruci D.
Lucarini V, et al. Among authors: tempora p.
J Exp Clin Cancer Res. 2022 Nov 17;41(1):326. doi: 10.1186/s13046-022-02525-9.
J Exp Clin Cancer Res. 2022.
PMID: 36397148
Free PMC article.
Item in Clipboard
Cite
Cite